NEW YORK (GenomeWeb News) – Oxford Gene Technology said today that it has acquired Cytocell for an undisclosed sum.

Cytocell, based in Cambridge, UK, offers a portfolio of fluorescence in situ hybridization probes that can be used to detect gene arrangements related to inherted diseases and cancer. Oxford, UK-based OGT said that Cytocell's products complement its CytoSure cytogenetics array and next-generation sequencing products.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.